<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Pan Afr Med J</journal-id>
      <journal-id journal-id-type="iso-abbrev">Pan Afr Med J</journal-id>
      <journal-id journal-id-type="publisher-id">PAMJ</journal-id>
      <journal-title-group>
        <journal-title>The Pan African Medical Journal</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1937-8688</issn>
      <publisher>
        <publisher-name>The African Field Epidemiology Network</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26161177</article-id>
      <article-id pub-id-type="pmc">4484323</article-id>
      <article-id pub-id-type="publisher-id">PAMJ-20-254</article-id>
      <article-id pub-id-type="doi">10.11604/pamj.2015.20.254.5710</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Hepatic primary neuroendocrine carcinoma: about a new case</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Derouich</surname>
            <given-names>Hasna</given-names>
          </name>
          <xref ref-type="aff" rid="AF0001">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Haddad</surname>
            <given-names>Fouad</given-names>
          </name>
          <xref ref-type="aff" rid="AF0001">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Moukhlissi</surname>
            <given-names>Mohamed</given-names>
          </name>
          <xref ref-type="aff" rid="AF0001">1</xref>
          <xref ref-type="corresp" rid="cor1">&amp;</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hliwa</surname>
            <given-names>Wafaa</given-names>
          </name>
          <xref ref-type="aff" rid="AF0001">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bellabah</surname>
            <given-names>Ahmed</given-names>
          </name>
          <xref ref-type="aff" rid="AF0001">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Badre</surname>
            <given-names>Wafaa</given-names>
          </name>
          <xref ref-type="aff" rid="AF0001">1</xref>
        </contrib>
      </contrib-group>
      <aff id="AF0001"><label>1</label>Gastroenterology, Oncology Departemnt Ibn Rochd Hospital, Casablanca, Morocco</aff>
      <author-notes>
        <corresp id="cor1"><label>&amp;</label>Corresponding author: Mohamed Moukhlissi, Gastroenterology, Oncology Departemnt Ibn Rochd Hospital, Casablanca, Morocco</corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>17</day>
        <month>3</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2015</year>
      </pub-date>
      <volume>20</volume>
      <elocation-id>254</elocation-id>
      <history>
        <date date-type="received">
          <day>03</day>
          <month>11</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>03</day>
          <month>3</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Mohamed Moukhlissi et al.</copyright-statement>
        <copyright-year>2015</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0/">
          <license-p>The Pan African Medical Journal - ISSN 1937-8688. This is an Open Access article distributed under the terms of the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>We report a new case of Primary hepatic neuroendocrine carcinoma admitted in our hospital and revealed in 53 years man by epigastric pain and flush syndrome. A liver biopsy with immunohistochemical study confirmed the original location of a neuroendocrine carcinoma. After 12 cures of Chemotherapy and a follow up of 12 months, the patient is still in complete remission.</p>
      </abstract>
      <kwd-group>
        <kwd>Carcinoma</kwd>
        <kwd>neuroendocrine</kwd>
        <kwd>liver</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro" id="S0001">
      <title>Introduction</title>
      <p>Endocrine tumors are characterized by a common phenotype general markers (i.e., neuron-specific enolase, chromogranin, synaptophysin) and hormonal secretion products. Primitive hepatic localization is very rare, representing less than 0.3% of all endocrine tumors of the digestive system with a female predominance; the sex ratio is 1.6 / 1, with an average age of 51 [<xref rid="CIT0001" ref-type="bibr">1</xref>, <xref rid="CIT0002" ref-type="bibr">2</xref>].</p>
    </sec>
    <sec id="S0002">
      <title>Patient and observation</title>
      <p>We report a case of primary hepatic neuroendocrine carcinoma (PHNEC) admitted in our departement. A 53 years old patient, known diabetic, admitted for epigastric pain combined with diarrhea, abdominal distension and flush syndrome. This evolved in a deterioration of general condition. The clinical exam attested a facial reddening, hepatomegaly. An abdominal ultrasound showed a giant hepatic hemangioma of the posterior segment. A thoraco-abdominal-pelvic CT objective tumor lesion localized segment VI and VII of the liver with ascites (<xref ref-type="fig" rid="F0001">Figure 1</xref>).</p>
      <fig id="F0001" orientation="portrait" position="float">
        <label>Figure 1</label>
        <caption>
          <p>CT scan image of a PHNEC patient; CT scan showing a liver mass (segment VI and VII)</p>
        </caption>
        <graphic xlink:href="PAMJ-20-254-g001"/>
      </fig>
      <p>Digestive endoscopy was performed for the patient and no Neoplasm was found in the stomach, duodenum, colon, or rectum. Capsule endoscopy for the small intestine was normal. Serum 5-HT, chromogranin A (CgA), and urinary 5-hydroxyindoleacetic acid (5-HIAA) examinations were very high with values of 225 ng/ml and 19 mg/24h successively. CT scan of the thorax was normal. The patient were Alpha Fetoprotein (AFP-), Carcinoembryonic antigen (CEA -) and Carcinoma Antigen (CA19-9-).</p>
      <p>A liver biopsy with immunohistochemical study confirmed the diagnosis of primary neuroendocrine carcinoma (<xref ref-type="fig" rid="F0002">Figure 2</xref>, <xref ref-type="fig" rid="F0003">Figure 3</xref>, <xref ref-type="fig" rid="F0004">Figure 4</xref>). The patient has received chemotherapy with Cisplatin 100 mg/m2/day J1 and Etoposide 100 mg/m2/day J1 to J3 for 6 months, with good clinical and radiological improvement, and then he undergone 6 months more treatments: 12 months of treatments in total. After 18 months of follow up, the patient is in complete remission and we opted for a clinical and radiological monitoring.</p>
      <fig id="F0002" orientation="portrait" position="float">
        <label>Figure 2</label>
        <caption>
          <p>Microscopic image at low magnification showing tumor proliferation</p>
        </caption>
        <graphic xlink:href="PAMJ-20-254-g002"/>
      </fig>
      <fig id="F0003" orientation="portrait" position="float">
        <label>Figure 3</label>
        <caption>
          <p>Hematoxylin eosin staining</p>
        </caption>
        <graphic xlink:href="PAMJ-20-254-g003"/>
      </fig>
      <fig id="F0004" orientation="portrait" position="float">
        <label>Figure 4</label>
        <caption>
          <p>Immunohistochemistry, chromogranin A</p>
        </caption>
        <graphic xlink:href="PAMJ-20-254-g004"/>
      </fig>
    </sec>
    <sec sec-type="discussion" id="S0003">
      <title>Discussion</title>
      <p>Primary hepatic neuroendocrine carcinoma is rare [<xref rid="CIT0001" ref-type="bibr">1</xref>, <xref rid="CIT0002" ref-type="bibr">2</xref>], clincal symptoms are not specific, and imaging is fundamental to guide diagnosis. Serum 5-HT or hydroxyindoleacetic acid (5-HIAA) 24 h urine levels may be effective markers with sensitivity of 73% and a specificity of more than 90%. Serum (CGA) is a sensitive marker in the diagnosis with a sensitivity of 87-100% and a specificity of 92%, but diagnosis confirmation is the histoligical examination after biopsy or surgery [<xref rid="CIT0003" ref-type="bibr">3</xref>].</p>
      <p>It is difficult to differentiate PHNEC from other solid tumors, especially hepatocellular carcinoma or hepatic metastasis of other tumor; therefore, postoperative pathologic examination is the main method for a final diagnosis [<xref rid="CIT0001" ref-type="bibr">1</xref>, <xref rid="CIT0004" ref-type="bibr">4</xref>]. Treatment includes several methods, surgery, systemic chemotherapy and transcatheter arterial chemoembo-lization [<xref rid="CIT0005" ref-type="bibr">5</xref>, <xref rid="CIT0006" ref-type="bibr">6</xref>]. Prognosis depends on the initial stage of the disease. Research indicated that the recurrence rate at 5 years was 18% and the survival rate at 5 years was 74% -78% [<xref rid="CIT0007" ref-type="bibr">7</xref>].</p>
    </sec>
    <sec sec-type="conclusion" id="S0004">
      <title>Conclusion</title>
      <p>Primary hepatic neuroendocrine carcinoma remains a rare diagnosis, requiring careful biological, endoscopic, radiological and histological examinations to eliminate the secondary localization of extrahepatic tumor.</p>
    </sec>
  </body>
  <back>
    <sec id="S0005">
      <title>Competing interests</title>
      <p>The authors declare no competing interest.</p>
    </sec>
    <sec id="S0006">
      <title>Authors&#x2019; contributions</title>
      <p>All authors read and agreed to the final version of this manuscript and equally contributed to its content and to the management of the case.</p>
    </sec>
    <ref-list>
      <title>References</title>
      <ref id="CIT0001">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yang-Qing</surname>
              <given-names>Huang</given-names>
            </name>
            <name>
              <surname>Feng</surname>
              <given-names>Xu</given-names>
            </name>
            <name>
              <surname>Jia-Mei</surname>
              <given-names>Yang</given-names>
            </name>
            <name>
              <surname>Bin</surname>
              <given-names>Huang</given-names>
            </name>
          </person-group>
          <article-title>Primary hepatic neuroendocrine carcinoma: clinical analysis of 11 cases</article-title>
          <source>Hepatobiliary Pancreat Dis Int.</source>
          <year>2010</year>
          <volume>9</volume>
          <issue>1</issue>
          <fpage>44</fpage>
          <lpage>48</lpage>
          <pub-id pub-id-type="pmid">20133228</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0002">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Benameur</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Primary endocrine tumor of the lever: adifficult diagnosis</article-title>
          <source>J Afr Hepatol Gastroenterol.</source>
          <year>2012</year>
          <volume>6</volume>
          <fpage>103</fpage>
          <lpage>106</lpage>
        </element-citation>
      </ref>
      <ref id="CIT0003">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ruo-Kun</surname>
              <given-names>Li</given-names>
            </name>
            <name>
              <surname>Jing</surname>
              <given-names>Zhao</given-names>
            </name>
            <name>
              <surname>Sheng-Xiang</surname>
              <given-names>Rao</given-names>
            </name>
            <name>
              <surname>Cai-Zhong</surname>
              <given-names>Chen</given-names>
            </name>
            <name>
              <surname>Meng-Su</surname>
              <given-names>Zeng</given-names>
            </name>
            <name>
              <surname>Jin-Wei</surname>
              <given-names>Qiang</given-names>
            </name>
          </person-group>
          <article-title>Primary hepatic neuroendocrine carcinoma: MR imaging findings including preliminary observation on diffusion-weighted imaging</article-title>
          <source>Abdom Imaging</source>
          <year>2013</year>
          <month>12</month>
          <volume>38</volume>
          <issue>6</issue>
          <fpage>1269</fpage>
          <lpage>76</lpage>
          <pub-id pub-id-type="pmid">23942951</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0004">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bastaki</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Mothaffer</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Varro</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Al-Ghanim</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Malak</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Ayyash</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Asfar</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Primary hepatic carcinoid tumor</article-title>
          <source>Med Princ Pract.</source>
          <year>2005</year>
          <season>Jul-Aug</season>
          <volume>14</volume>
          <issue>4</issue>
          <fpage>288</fpage>
          <lpage>91</lpage>
          <pub-id pub-id-type="pmid">15961944</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0005">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Iwao</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Nakamuta</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Enjoji</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kubo</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Fukutomi</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Tanabe</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Primary hepatic carcinoid tumor: case report and review of 53 cases</article-title>
          <source>Med Sci Monit.</source>
          <year>2001</year>
          <season>Jul-Aug</season>
          <volume>7</volume>
          <issue>4</issue>
          <fpage>746</fpage>
          <lpage>50</lpage>
          <pub-id pub-id-type="pmid">11433205</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0006">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bloomston</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Al-Saif</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Klemanski</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Pinzone</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>EW</given-names>
            </name>
            <name>
              <surname>Palmer</surname>
              <given-names>B</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Hepatic artery chemoembolization in 122 patients with metastatic carcinoid tumor: lessons learned</article-title>
          <source>J Gastrointest Surg.</source>
          <year>2007</year>
          <month>3</month>
          <volume>11</volume>
          <issue>3</issue>
          <fpage>264</fpage>
          <lpage>71</lpage>
          <pub-id pub-id-type="pmid">17458596</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0007">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Knox</surname>
              <given-names>CD</given-names>
            </name>
            <name>
              <surname>Anderson</surname>
              <given-names>CD</given-names>
            </name>
            <name>
              <surname>Lamps</surname>
              <given-names>LW</given-names>
            </name>
            <name>
              <surname>Adkins</surname>
              <given-names>RB</given-names>
            </name>
            <name>
              <surname>Pinson</surname>
              <given-names>CW</given-names>
            </name>
          </person-group>
          <article-title>Long-term survival after resection for primary hepatic carcinoid tumor</article-title>
          <source>Ann Surg Oncol.</source>
          <year>2003</year>
          <month>12</month>
          <volume>10</volume>
          <issue>10</issue>
          <fpage>1171</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="pmid">14654473</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
